(Q24247507)

2 July 2019

review article

1 reference

title

Rotavirus vaccine for preventing diarrhoea (English)

1 reference

2 July 2019

0 references

0 references

1 reference

4

0 references

1

K Soares-Weiser

K

Soares-Weiser

1 reference

19 October 2023

5

L Leibovici

1 reference

2 July 2019

E Goldberg

2

E

Goldberg

2 references

2 July 2019

19 October 2023

G Tamimi

series ordinal

3

author given names

G

author last names

Tamimi

2 references

2 July 2019

19 October 2023

O C Pitan

author given names

O C

author last names

Pitan

series ordinal

4

1 reference

19 October 2023

publication date

1 January 2004

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

issue

1

1 reference

2 July 2019

page(s)

CD002848

1 reference

2 July 2019

Protection from Rotavirus Reinfection: 2-Year Prospective Study

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Failure of live, attenuated oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Asymptomatic infections due to wild-type rotavirus may prime for a heterotypic response to vaccination with rhesus rotavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Effect of maternal rotavirus immunization on milk and serum antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Simultaneous Administration of Two Human-Rhesus Rotavirus Reassortant Strains of VP7 Serotype 1 and 2 Specificity to Infants and Young Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Meta-analysis, Simpson's paradox, and the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

The link between rotavirus vaccination and intussusception: implications for vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Rotavirus vaccines: development, current issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Selected regulatory and scientific topics for candidate rotavirus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Intussusception, rotavirus, and oral vaccines: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Rotavirus vaccines against diarrhoeal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

The future of research into rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Economic Impact of Immunization Against Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Protection against Rotavirus Disease after Natural Rotavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002848.PUB2

First rotavirus vaccine licensed: is there really a need?

21 January 2018

1 reference

12 December 2020

Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis

1 reference

12 December 2020

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

1 reference

12 December 2020

Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines

1 reference

12 December 2020

Human astrovirus-associated gastroenteritis in children under 2 years of age followed prospectively during a rotavirus vaccine trial

1 reference

12 December 2020

Intussusception among recipients of rotavirus vaccine--United States, 1998-1999

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999

1 reference

12 December 2020

Effect of rhesus rotavirus vaccine on enteric adenovirus--associated diarrhea in children

1 reference

12 December 2020

Withdrawal of rotavirus vaccine recommendation

1 reference

12 December 2020

Rotavirus W179-9 vaccine (Merck and Co)

1 reference

12 December 2020

Future of research into rotavirus vaccine. Developing countries must apply mathematics to take their own decisions

1 reference

12 December 2020

Efficacy of monovalent human rotavirus vaccine 89-12 in infants

1 reference

12 December 2020

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants

1 reference

12 December 2020

Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination

1 reference

12 December 2020

Rotavirus vaccine AVANT/GlaxoSmithKline.

1 reference

12 December 2020

Clinical evaluation of a single oral dose of human-bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS-1 x UK) (P1A[8],G2)

1 reference

12 December 2020

More on rotavirus vaccination and intussusception

1 reference

12 December 2020

Early phase II trial of human rotavirus vaccine candidate RV3

1 reference

12 December 2020

Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants

1 reference

12 December 2020

Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus

1 reference

12 December 2020

Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups

1 reference

12 December 2020

Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity

1 reference

12 December 2020

Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates

1 reference

12 December 2020

Immunogenicity of Tetravalent Rhesus Rotavirus Vaccine Administered With Buffer and Oral Polio Vaccine

1 reference

12 December 2020

Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity

1 reference

12 December 2020

Safety and Immunogenicity of Human Rotavirus Vaccine Strain M37 in Adults, Children, and Infants

1 reference

12 December 2020

Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.

1 reference

12 December 2020

Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine

1 reference

12 December 2020

A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population

1 reference

12 December 2020

Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age

1 reference

12 December 2020

Evaluation of a reassortant rhesus rotavirus vaccine in young children

1 reference

12 December 2020

Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants

1 reference

12 December 2020

Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group

1 reference

12 December 2020

Impact of rotavirus infection at a large pediatric hospital

1 reference

12 December 2020

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

1 reference

12 December 2020

An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group

1 reference

12 December 2020

Prolonged efficacy of rhesus rotavirus vaccine in Swedish children

1 reference

12 December 2020

Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.

1 reference

12 December 2020

A trial of RIT-4237 rotavirus vaccine in 1-month-old infants

1 reference

12 December 2020

Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity

1 reference

12 December 2020

Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates

1 reference

12 December 2020

Response to RIT 4237 oral rotavirus vaccine in human milk, adapted-and soy-formula fed infants

1 reference

12 December 2020

Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines.

1 reference

12 December 2020

Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation

1 reference

12 December 2020

Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine

1 reference

12 December 2020

Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.

1 reference

12 December 2020

Field trial of rhesus rotavirus vaccine in infants

1 reference

12 December 2020

[Oral vaccination with live attenuated rotavirus]

1 reference

12 December 2020

Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela

1 reference

12 December 2020

Live attenuated oral rotavirus vaccine

1 reference

12 December 2020

Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants

1 reference

12 December 2020

Rotavirus infections and their prevention by vaccination

1 reference

12 December 2020

Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants

1 reference

12 December 2020

Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children

1 reference

12 December 2020

Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months

1 reference

12 December 2020

Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants

1 reference

12 December 2020

Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children

1 reference

12 December 2020

Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine

1 reference

12 December 2020

Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain

1 reference

12 December 2020

Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report

1 reference

12 December 2020

Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children

1 reference

12 December 2020

Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants

1 reference

12 December 2020

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine

1 reference

12 December 2020

Increased "take" rate of oral rotavirus vaccine in infants after milk feeding

1 reference

12 December 2020

Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants

1 reference

12 December 2020

Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG

1 reference

12 December 2020

Tetravalent rhesus rotavirus vaccine in young infants

1 reference

12 December 2020

Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine

1 reference

12 December 2020

Evaluation of a bovine-human rotavirus reassortant vaccine in infants

1 reference

12 December 2020

Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children

1 reference

12 December 2020

Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns

1 reference

12 December 2020

Take of rhesus-human reassortant tetravalent rotavirus vaccine in breast-fed infants

1 reference

12 December 2020

A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants

1 reference

12 December 2020

Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine

1 reference

12 December 2020

Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.

1 reference

12 December 2020

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

1 reference

12 December 2020

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

12 December 2020

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants

1 reference

12 December 2020

Cost-effectiveness analysis of a rotavirus immunization program for the United States

1 reference

12 December 2020

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

12 December 2020

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

1 reference

12 December 2020

Prolonged efficacy of rhesus-human reassortant rotavirus vaccine

1 reference

12 December 2020

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

1 reference

12 December 2020

Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine

1 reference

12 December 2020

Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group

1 reference

12 December 2020

Lack of an apparent association between intussusception and wild or vaccine rotavirus infection

1 reference

12 December 2020

Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics

1 reference

12 December 2020

10.1002/14651858.CD002848.PUB2

Identifiers

DOI

1 reference

2 July 2019

release_ksjowh7ztfdvripma7wflpzhhi

Fatcat ID

0 references

PMC publication ID

6532746

1 reference

2 July 2019

1 reference

2 July 2019